Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
December 12, 2024
Toward Dose Prediction at Point of Design
Dries Van Rompaey, Siladitya Ray Chaudhuri, Mazen Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 11, 2018
Identification and biological evaluation of thiazole-based inverse agonists of RORγt
Christian Gege, Maxwell D Cummings, Michael Albers, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2024
Identification of isoquinolinone DHODH inhibitor isosteres
Lindsey G DeRatt, Zhuming Zhang, E Christine Pietsch, et al.
European Journal of Pharmacology
|
May 22, 2020
Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse
William A Eckert, John J M Wiener, Hui Cai, et al.
Journal of Medicinal Chemistry
|
August 4, 2022
<i>N</i>-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia
Justin S Cisar, Christine Pietsch, Lindsey G DeRatt, et al.
Journal of Medicinal Chemistry
|
April 19, 2007
Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones
Robert I Higuchi, Kristen L Arienti, Francisco J López, et al.
The Journal of Organic Chemistry
|
April 4, 1997
Acyclic Stereoselection in the Ortho Ester Claisen Rearrangement
G. William Daub, James P. Edwards, Carol R. Okada, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt
Christian Gege, Michael Albers, Olaf Kinzel, et al.
Journal of Medicinal Chemistry
|
June 18, 2024
Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML
Lindsey G DeRatt, Zhuming Zhang, Christine Pietsch, et al.
Journal of Medicinal Chemistry
|
July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity
Cheryl A Grice, Kevin L Tays, Brad M Savall, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
December 12, 2024
Toward Dose Prediction at Point of Design
Dries Van Rompaey, Siladitya Ray Chaudhuri, Mazen Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 11, 2018
Identification and biological evaluation of thiazole-based inverse agonists of RORγt
Christian Gege, Maxwell D Cummings, Michael Albers, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2024
Identification of isoquinolinone DHODH inhibitor isosteres
Lindsey G DeRatt, Zhuming Zhang, E Christine Pietsch, et al.
European Journal of Pharmacology
|
May 22, 2020
Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse
William A Eckert, John J M Wiener, Hui Cai, et al.
Journal of Medicinal Chemistry
|
August 4, 2022
<i>N</i>-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia
Justin S Cisar, Christine Pietsch, Lindsey G DeRatt, et al.
Journal of Medicinal Chemistry
|
April 19, 2007
Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones
Robert I Higuchi, Kristen L Arienti, Francisco J López, et al.
The Journal of Organic Chemistry
|
April 4, 1997
Acyclic Stereoselection in the Ortho Ester Claisen Rearrangement
G. William Daub, James P. Edwards, Carol R. Okada, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt
Christian Gege, Michael Albers, Olaf Kinzel, et al.
Journal of Medicinal Chemistry
|
June 18, 2024
Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML
Lindsey G DeRatt, Zhuming Zhang, Christine Pietsch, et al.
Journal of Medicinal Chemistry
|
July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity
Cheryl A Grice, Kevin L Tays, Brad M Savall, et al.
Page
of 8